UBS downgraded CME Group from Buy to Neutral and set a new price target of $305.00
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/24/2025 | $305.00 | Buy → Neutral | UBS |
| 4/8/2025 | $301.00 | Equal-Weight → Overweight | Morgan Stanley |
| 3/10/2025 | $287.00 | Mkt Perform → Outperform | Raymond James |
| 1/6/2025 | $255.00 → $250.00 | Buy → Neutral | Citigroup |
| 10/8/2024 | $244.00 | Buy → Neutral | Redburn Atlantic |
| 9/27/2024 | $235.00 | Sector Perform | RBC Capital Mkts |
| 9/26/2024 | $221.00 | Hold | TD Cowen |
| 9/3/2024 | $212.00 → $177.00 | Neutral → Underperform | BofA Securities |
4 - CME GROUP INC. (0001156375) (Issuer)
4 - CME GROUP INC. (0001156375) (Issuer)
4 - CME GROUP INC. (0001156375) (Issuer)
Record revenue of $1.7 billion, up 10% from Q2 2024Record average daily volume (ADV) of 30.2 million contracts, up 16% from Q2 2024CHICAGO, July 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the second quarter of 2025. The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2025. Net income was $1.0 billion and diluted earnings per common share were $2.81. On an adjusted basis, net income was $1.1 billion and diluted earnings per common share were $2.96. Financial results presented on an adjusted basis for the second quarter of 2025 and 2024 exclude certain items, which are detailed in the reconc
CHICAGO, July 22, 2025 /PRNewswire/ -- CME Group and Nasdaq (NASDAQ:NDAQ) today announced a ten-year extension of CME Group's exclusive license to offer futures and options on futures based on the Nasdaq-100 and other Nasdaq indexes, through 2039. As the world's leading derivatives marketplace, CME Group operates the largest equity index futures complex in the world. Nasdaq is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. "Extending our exclusive licensing agreement with Nasdaq will ensure that global market participants continue to have seamless access to our deeply liquid Nasdaq futures and options on futures, which
Record Europe, Middle East and Africa (EMEA) ADV of 6.7M, up 15% in Q2 2025Record Asia Pacific (APAC) ADV of 2.2M, up 30% in Q2 2025LONDON and SINGAPORE, July 10, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 9.2 million contracts in Q2 2025, up 18% year over year. Reflecting all trading reported outside the United States, this growth was driven by record quarterly ADV in EMEA and APAC. Quarterly international records were achieved in Interest Rate, Equity Index, Energy, Agricultural and Metals products up 14%, 38%, 23%, 3% and 14% respectively. "During this period of
8-K - CME GROUP INC. (0001156375) (Filer)
10-Q - CME GROUP INC. (0001156375) (Filer)
8-K - CME GROUP INC. (0001156375) (Filer)
SC 13G/A - CME GROUP INC. (0001156375) (Subject)
SC 13G/A - CME GROUP INC. (0001156375) (Subject)
SC 13G/A - CME GROUP INC. (0001156375) (Subject)
Record revenue of $1.7 billion, up 10% from Q2 2024Record average daily volume (ADV) of 30.2 million contracts, up 16% from Q2 2024CHICAGO, July 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the second quarter of 2025. The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2025. Net income was $1.0 billion and diluted earnings per common share were $2.81. On an adjusted basis, net income was $1.1 billion and diluted earnings per common share were $2.96. Financial results presented on an adjusted basis for the second quarter of 2025 and 2024 exclude certain items, which are detailed in the reconc
CHICAGO, June 17, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the second quarter of 2025 before the markets open on Wednesday, July 23, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions. A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing to
CHICAGO, May 8, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.25 per share. The dividend is payable June 25, 2025 to shareholders of record as of June 9, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultu
UBS downgraded CME Group from Buy to Neutral and set a new price target of $305.00
Morgan Stanley upgraded CME Group from Equal-Weight to Overweight and set a new price target of $301.00
Raymond James upgraded CME Group from Mkt Perform to Outperform and set a new price target of $287.00
CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was
CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division. With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our
Chicago , April 23, 2025 (GLOBE NEWSWIRE) -- Sterling Trading Tech (Sterling), a leading global provider of technology in order management, risk and margin, and trading, announced today the appointment of Julie Armstrong as Chief Commercial Officer, a newly created role that underscores the firm's commitment to scaling its business globally. This strategic hire signals Sterling's transition into its next phase of accelerated growth, building on recent momentum across new client segments, product innovation, asset expansion, and geographic reach. Armstrong, a recognized industry expert, brings decades of experience in global fintech strategy and revenue generation. She will lead Sterling'
4 - CME GROUP INC. (0001156375) (Issuer)
4 - CME GROUP INC. (0001156375) (Issuer)
4/A - CME GROUP INC. (0001156375) (Issuer)